PLACENTAL GROWTH FACTOR AND CORONARY NEOANGIOGENESIS IN CORONARY HEART DISEASE
Neoangiogenesis in coronary heart disease is a protective reaction aimed to improve ischemic myocardial perfusion, by increasing the number and size of arterial collaterals. Placental growth factor (PlGF) is one of the key peptides regulating angiogenic processes in atherosclerosis. In particular, a...
Main Authors: | M. V. Tulikov, O. P. Shevchenko, A. O. Shevchenko, A. V. Gagayev, V. V. Pavlov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Klinicist |
Subjects: | |
Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/35 |
Similar Items
-
PLACENTAL GROWTH FACTOR AND CORONARY NEOANGIOGENESIS IN CORONARY HEART DISEASE
by: M. V. Tulikov, et al.
Published: (2014-07-01) -
Diagnostic value of placental growth factor in patients with coronary heart disease
by: M. V. Tulikov, et al.
Published: (2014-07-01) -
Diagnostic value of placental growth factor in patients with coronary heart disease
by: M. V. Tulikov, et al.
Published: (2014-07-01) -
Pregnancy-associated plasma protein – a new biochemical marker of acute coronary syndrome and poor prognosis predictor in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (2006-08-01) -
Hemorheological system in coronary heart disease patients: prognostic value
by: L. I. Malinova, et al.
Published: (2007-06-01)